NEW YORK (GenomeWeb News) – Partners & Partners will be the sole distributor of Aviir's tests and technologies in 19 countries in the Middle East and North Africa as part of a deal announced today.

P&P will roll out a network, country by country, to distribute and promote Aviir's tests —including the Aviir MIRISK VP Assessment test for assessing an individual's risk for developing a heart attack — through its affiliate Qatar Heart Laboratory Holding, Aviir said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.